Safety and Efficacy of "Immuncell-LC" in TACE Therapy
Clinical trial NCT02856815 · COMPLETED
Trial details
- NCT number
- NCT02856815
- Sponsor
- GC Cell Corporation
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-28
- Primary completion
- 2020-08-11
- Enrollment
- 76
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.